image_pdfimage_print
20 04, 2022

HM 36

Hospital Charges for Uninsured. A memorial: requesting the legislative health and human services committee to hold a hearing on hospital charges for New Mexico's uninsured patients and for the Human Services Department to report on New Mexico hospitals' use of public funds and provisions for financial assistance for uninsured patients.

HM 36
2 11, 2021

Spotlight on State: New Mexico

This is part of a series of summaries that highlight notable legislation and initiatives in health policy and reform of all 50 states. Check back on The Source as we roll out additional states each week. See New Mexico page. New Mexico has made strides in healthcare price transparency and cost control. After a legislative mandate was enacted to establish an all-payer claims database, the state began its implementation with budget allotted in the 2019-2020 fiscal year. In recent terms, New Mexico also passed the Surprise Billing Protection Act, which requires a provider to [...]

Spotlight on State: New Mexico
21 10, 2021

HB 34

Podiatric Services Cost Sharing Limits. House Bill 34 would dictate that insurance products for sale in New Mexico could not impose a higher coinsurance percentage or copay amount on a consumer for services provided by a podiatrist than for primary care services, defined in each of the bill’s sections as “the first level of basic or general health care for a person’s health needs.”

HB 34
21 10, 2021

HB 129

House Bill 129 would amend and add new subsections to Section 59A-61 NMSA 1978 (the Pharmacy Benefit Manager Regulation Act, part of the Insurance Code) to increase transparency of operations of pharmacy benefit managers (PBMs) operating in New Mexico.

HB 129
21 10, 2021

HB 154

Prescription Drug Affordability Act: House Bill 154 would create a five-member prescription drug affordability board, the purpose of which is to take action to protect state residents and other stakeholders from the high cost of prescription drugs, Board members would be appointed for their expertise in clinical medicine or health economics and would not be employees of or consultants to pharmaceutical companies or their trade associations. The prescription drug affordability board would consider drugs having a high acquisition cost, specified in the bill, whether they be brand name or generic, as well as those [...]

HB 154
21 10, 2021

SB 382

Senate Bill 382 establishes a new section of the Unfair Practices Act (Chapter 57-12 NMSA 1978) to apply to hospital billing. It would require that a hospital bill from an episode of care be provided within sixty days of the end of that episode, or ninety days if the hospital were still negotiating with a third-party payer. The bill would be required to specify which services are provided by providers participating in the patient’s health plan network, and which were not, and would clearly state which parts of the bill were to be paid [...]

SB 382